Exam 3 Renal Disorders Flashcards

1
Q

S/ SX of Dysuria

A
  • Subjective experience of pain or a burning sensation on urination
  • Frequency, urgency, hesitation
  • Can be secondary to several medical conditions or certain medications
  • Most commonly associated with lower urinary system infections
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Dysuria: Differential Diagnosis

A
  • Most often associated with a bladder problem and rarely with renal disease
  • Inflammatory lesions of the prostate, bladder, and urethra
  • Other conditions associated with dysuria
    o Bladder tumors
    o Chronic renal failure
    o Nephrolithiasis
    o Disease of upper urinary system
  • Outside the renal system
    o STIs
    o Vaginitis and prostatitis
  • Women should be questioned about vaginal discharge or irritation
  • Symptoms may lead to other diagnoses
    o Urethral strictures
    o Prolapsed uterus
    o Pelvic peritonitis
    o Cancer of the cervix or prostate
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Dysuria: Diagnostic Testing

A
  • Urinalysis is the easiest, most noninvasive, and most economical way to identify UTIs and other renal problems.
  • Once the associated condition is identified, appropriate treatment can begin.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Hematuria: Clinical presentation

A
  • Color of the urine
  • Concurrent symptoms?
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Hematuria: History

A
  • Medications & dietary history
  • Menstrual history
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Hematuria: Differential diagnosis

A
  • UTI / pyleo
  • Cancers
  • BPH
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Hematuria: Physical exam

A
  • Abdominal exam – tenderness, masses, CVA tenderness, pelvic / prostate exam
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Hematuria: Diagnostic tests

A
  • Urinalysis, C&S
  • ANA, CMP, CBC,
  • IVP, cystoscopy
  • Ultra sound
  • CT scan
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Hematuria: Management and follow-up

A
  • Antibiotic therapy if bacterial infection found
  • Refer for further evaluation – urology or nephrology
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Lower Urinary Tract Infection (UTI) differentiate between acute, chronic and complicated UTI

A
  • Acute infections
    Characterized by the onset of UTI in a previously symptom-free individual
  • Chronic infections
    Caused by obstructions, antibiotic-resistant bacteria, presence of multiple strains of bacteria
  • Complicated UTI
    Accompanied by factors that complicate the infection
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Type of Lower Tract UTI

A

o Urethra: urethritis
o Bladder: cystitis
o Bladder wall: interstitial cystitis (IC)
o Prostate gland: prostatitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Lower UTI: Clinical Presentation

A
  • Most frequently reported symptoms
    o Dysuria
    o Urinary frequency or urgency
    o Nocturia
    o Hematuria
    o Low back or suprapubic pain
    o Urinary incontinence
    o Cloudy, foul-smelling urine
    o Altered mental status in elderly
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Lower UTI: Clinical Presentation UA

A

Urinalysis may exhibit
o Cloudy appearance
o Alkaline pH
o Hematuria
o Elevated levels of nitrites
o Leukocyte esterase
Urine sediments of
o RBCs, WBCs, mucus, and bacterial overgrowth

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Lower UTI: Diagnostic Testing

A
  • Urinalysis
    o Clean-catch, midstream urine sample
    o Sample showing more than 100,000 organisms/mL is indicative of infection
    o PLUS presence of characteristic clinical symptoms
  • Urine culture is considered the gold standard for laboratory confirmation of UTI
  • Urinalysis with microscopy
  • Urine culture and sensitivity
  • IC: potassium sensitivity test (PST)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Lower UTI: Differential Diagnosis

A
  • Differential diagnosis
    o Tumors
    o Upper UTI
    o Vaginitis
    o STDs
  • Lower UTI does not exhibits signs of sepsis (fever, chills, WBC casts, CVAT)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Lower UTI: Management Uncomplicated

A
  • Pharmacological antimicrobial management is the mainstay of treatment
    o Nitrofurantoin (Macrobid) seems to be the most effective on gram-negative and gram-positive cocci;100 mg BID 7-day regimen 🡪 does not work in males!
    o Trimethoprim-sulfamethoxazole (Bactrim DS/Septra DS) is also effective; 1 DS x 3-day regimen for uncomplicated UTI
    o Amoxicillin; 500mg BID x 3 days
    o The fluoroquinolones have widespread efficacy
     BLACKLISTED for female patients, male patients be cautious…typically reserved for serious infections
  • Ampicillin and sulfonamides are becoming increasingly resistant
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Lower UTI: Management Complicated UTI

A

o Ciprofloxacin 500mg po BID x 7-14 days
o Levaquin 250 mg po daily x 10 days or 750 mg daily x 5 days
* Do NOT use the same medication if one has been used in the last 3 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Lower UTI: Management Pregnancy

A
  • During pregnancy
    o Especially important as an established link exists between premature delivery and UTI
    o Empirical therapy: amoxicillin 500mg po QID, nitrofurantoin 100 mg po BID x 7 days, or cephalexin (Keflex) 500 mg po QID x 7 days
    o Most treatment is 1 week
    o No Fluoroquinolones!!
    o No Bactim or Septra in the 1st or 3rd trimester of pregnancy!
    o History of UTI: postcoital prophylaxis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Lower UTI: Management
Fungal

A

fluconazole 200 mg qd 7–14 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Lower UTI: Management
Chronic UTI

A

o Who should receive prophylaxis?
 2 or more symptomatic UTIs w/in 6 months
 3 or > within 12 months
* Prophylaxis should be initiated after previous UTI resolution is confirmed
* Daily dosing for 6 months
* Post-coital prophylaxis
* Self-medication (3-4 days of therapy when symptoms begin)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Lower UTI: Follow-up and Referral

A
  • Midstream, clean-catch urine sample for urinalysis
  • Indwelling catheters should be changed every 4–6 weeks
  • Maintain adequate hydration and monitor urine output
  • Obstructions must be identified and removed
  • Prescribe analgesics for patients to reduce pain associated with UTI
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Lower UTI: Patient Education

A
  • Instruct patient to notify clinician if flank pain, hematuria, or lack of response to treatment occurs
  • Advise patient to
    o Complete full course of antibiotic therapy
    o Increase fluid intake to eight 8-ounce glasses of H2O
    o Take cranberry supplement and drink cranberry juice
    o Wear cotton underclothes
    o Avoid harsh soaps or feminine hygiene productsUse condoms
    o Use proper self-catheterization techniques
    o Empty bladder frequently, completely, and after sexual intercourse
    o Take showers instead of tub baths
    o Self-medicate as indicated
    o Keep a diary of urinary symptoms
    o Proper hygiene
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

UTI Males: Clinical presentation

A

-dysuria
-urgency/frequency
-cloud urine

24
Q

UTI Males: Treatment

A
  • Treat 10 to 14 days:
  • No macrolide
    o can still use Macrobid 100 mg po BID (as long as there is NO Prostatitis)
    o Bactrim DS 1 tab po BID
    o If associated with prostatitis
  • Ciprofloxacin 500 mg po BID or 1000 mg ER po daily
  • Levaquin 750 mg po Qday is only used for severe cases
25
UTI Males: Differential Diagnosis
* Prostititis * BPH * STI
26
UTI Males: Diagnostic Testing
o UA/C+S o Consider IVP or cystoscopy
27
Interstitial Cystitis (IC): Clinical Presentation
Chronic inflammatory condition of the bladder clinically characterized by irritable voiding symptoms or urgency and frequency, in the absence of objective evidence of another disease
28
Interstitial Cystitis (IC): Aggravating Factors
intercourse perimenstrual status
29
Interstitial Cystitis: Diagnostic Testing
* Lab: diagnosis of exclusion GYN, U/S, IVP, Cystoscopy * PUF Symptom Scale (>5, IC likely) *Intravesical Potassium Sensitivity Test
30
Interstitial Cystitis: Management
* Oral Pentosan polysulfate sodium: 100mg TID or 200mg BID * Course duration: 2-4 months minimum * Intravesical DMSO bladder instillation * Bladder training (reduce eliminations) * Hydro-distension of the bladder * laser * low acid diet * NSAIDS, antidepressants, muscle relaxants
30
Pyelonephritis: Clinical Presentation Acute vs Chronic
Acute o May present with sudden onset of fever, shaking, chills, nausea, vomiting, unilateral or localized flank pain, fatigue, diarrhea o Otherwise may be largely asymptomatic o Elderly patients may present with altered mentation Chronic o fatigue, nausea, decreased appetite with weight loss, nocturia and/or polyuria, symptoms of renal failure o Usually first diagnosed when patient presents with impaired renal function caused by damage to the kidneys
31
Pyelonephritis: Clinical Presentation- Physical exam
o Marked tenderness on deep abdominal palpation o May be hypertensive
32
Pyelonephritis: Diagnostic Testing
* Diagnosis confirmed through urinalysis & CNS, which is positive for bacteria, proteinuria, leukocyte esterase, urinary nitrites, hematuria, pyuria, and WBC casts * Urine culture, which typically demonstrates greater than 100,000 cfu/mL * Blood cultures * Cystoscopy with ureteral catheterization * Renal ultrasound or IVP
33
Pyelonephritis: Differential Diagnosis
* Difficult to differentiate from cystitis; however, presence of WBC casts is diagnostic for pyelonephritis * Definitive diagnosis for chronic disease is made by identifying persistent pyuria and by positive urine cultures * Kidney biopsy is sometimes appropriate for diagnosis
33
Pyelonephritis: Differential Diagnosis
* Difficult to differentiate from cystitis; however, presence of WBC casts is diagnostic for pyelonephritis * Definitive diagnosis for chronic disease is made by identifying persistent pyuria and by positive urine cultures * Kidney biopsy is sometimes appropriate for diagnosis
34
Pyelonephritis: Management
* Aggressive therapy is necessary to prevent permanent damage * Oral antibiotics for mild cases o Septra DS or Cipro (cautiously!) * Hospitalization of patients who are pregnant, vomiting, or dehydrated should be considered * Treatment courses should typically last 7–10 days for mild to moderate, 14 days for severe, and 21 days for particularly slow responders * If patient does not respond within 48 hours o Reevaluate patient and cultures o Consider hospitalization o Ultrasound, IVP, or dimercaptosuccinic acid (DMSA) renal scan o IV antibiotics o Increase fluid intake and maintain an accurate intake and output record o Surgery may be indicated o Diagnostic studies requiring insertion of instruments should be delayed
35
Pyelonephritis: Follow-up and Referral
* Patient should be assessed 48 hours later to assess responsiveness to therapy and consideration for discharge * Recurrent pyelonephritis o Reculture at 2, 6, and 12 weeks after antibiotic therapy is initiated * Chronic pyelonephritis: refer to nephrologist
36
Pyelonephritis: Patient Education
* Focus is on preventing recurrence o Complete antibiotic therapy o Prevent lower UTIs * Increase fluid intake * Report recurrence of any symptoms immediately * Take cranberry supplements and drink cranberry juice * Control hypertension with medications
37
Kidney Stones: Different Kinds
Stones form from o Calcium * o Struvite o Uric acid o Cystine
38
Kidney Stones: Clinical Presentation
* Sudden flank pain * Can radiate to abdomen, groin, perineal, and inner thigh * Nausea/vomiting * Urinary frequency * Diaphoresis * Dysuria * Hematuria * Weakness
39
Kidney Stones: Physical Exam
Vital signs * Elevated BP, tachycardia, tachypnea Systemic * fever Abdomen * Distended * Guarding * Decreased/absent bowel sounds * CVA tenderness
40
Kidney Stones: Diagnostics
UA o Normal to hematuria and leukocytes o Crystals and cast o Pus o Alkaline or acidic pH CBC-infection? CMP Renal/bladder ultrasound Bladder x-ray Noncontrast CT
41
Kidney Stones: Differential Diagnosis
Appendicitis UTI Pyelonephritis PUD Ovarian cyst Tubal pregnancy Renal/bladder cancer
42
Kidney Stones: Treatment
 Pain relief * Oral NSAIDs * Oral Opiates * Antispasmodics * Warm compresses * Focused breathing/diversional therapy Thiazide diuretics-calcium Allopurinol-uric acid D-penicillamine-cystine Increase water intake Noninvasive and invasive surgical interventions May need hospitalization for severe symptoms/referral Avoid medications that can cause stone formation * TUMs * Loop diuretics * Vitamin supplements
43
Chronic Kidney Disease: Clinical Presentation
Usually asymptomatic until GFR declines 10-15% from normal  Anorexia  Lassitude  Fatigability  Weakness  Pruritus and dry skin  N/V  Hiccups  Emotional lability  Depression  Insomnia  Confusion  Bruising  Peripheral Neuropathy  Edema  Headaches  Urine odor to breath  Metallic taste  Impotence  Nocturia  Muscle cramps  Gout  Pale  Frost appearance to urine  Ascites  Proteinuria  Crackles in lungs  Pericardial rub  Elevated BP
44
CKD: Diagnostics
 BMP  BUN, creatinine, and creatinine clearance  GFR Staging:  Stage 1 * Persistent Albuminuria, normal GFR  Stage 2 * Persistent Albuminuria, GFR between 60 and 89  Stage 3 * GFR between 30 and 59  Stage 4 * GFR between 15 and 29  Stage 5 * ESRD, GFR less than 15  CBC o Anemia  UA o Proteinuria  24-hour urine studies  Renal ultrasound  Renal CT, CT angiography  MRI/MRA  Duplex Doppler ultrasonography
45
CKD: Management
 Control any underlying comorbidities * HTN – Target BP 125/75 (JNC 8 says <140/90?)  DM  Anemia  Fluid restriction  Sodium restriction  Protein restriction (0.58g/kg daily)  Adequate caloric daily intake (40-50cal/kg daily)  Referrals  Nephrology  Nutritionist
46
Urinary Incontinence: Stress Clinical Presentation
 Increase in abdominal pressure results in loss of urine  Urethral sphincter muscle is weak  Weakness in pelvic floor muscles (preg, menopuas)  Brought on by coughing, sneezing, straining  Small Leakage
47
Urinary Incontinence: Stress Incontinence Management
* Kegels: 40 to 60 contractions daily o Slow tighten for 10 seconds, hold for 10 seconds, release over 10 seconds  Pelvic floor muscle training (PFMT)  Vaginal cones or pessaries o Must be measured, have to be resized after baby or weight changes  Lose weight  Limit fluids and diuretics in evening  Dietary changes and quit smoking  Meds: vaginal estrogen  Surgical intervention
48
Urge Incontinence: Urge Incontinence
 Detrusor instability  Involuntary leakage of urine resulting from inability to delay voiding  Patient has sensation of a full bladder, but cannot store urine long enough to reach the bathroom
49
Urge Incontinence: Urge Incontinence Management
Anticholinergic medications Tricyclic antidepressants
50
Urge Incontinence: Overflow Incontinence
 Involuntary leakage of small amounts of urine  Caused by over-distended bladder in an individual who does not feel sensation to void  Caused by outlet obstruction, BPH, medications
51
Urge Incontinence: Overflow Incontinence Management
Treatment of underlying cause Indwelling catheterization
52
Overactive Bladder (OAB): Clinical Presentation
 Unable to postpone--urgency
53
Overactive Bladder (OAB) Management Non-Medication
 Behavioral therapy techniques: bladder training, urgency control strategies  Avoid bladder irritants o Common bladder irritants: cold remedies (Sudafed), chocolate, carbonation, colas, citrus, cranberry juice or pills, vitamin C, certain wines and beers, Crystal Light, candy and high sugar foods, smoking
54
Overactive Bladder (OAB) Management Medication
 Anticholinergic /Antimuscarinic Medications o Oxybutynin – Ditropan and Ditropan XL po and patch o Trospium Chloride – Sanctura o Tolterodine - Detrol and Detrol LA o Solifenacin – Vesicare o Fesoterodine - Toviaz  Major side effects: dry mouth, urinary retention, constipation, blurred vision (caution in elderly and in glaucoma)